901 – 910 of 1299
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
-
Mark
Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients
(
- Contribution to journal › Article
-
Mark
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology
(
- Contribution to journal › Article
-
Mark
The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson’s disease and healthy controls
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Author response
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Familial associations of monoclonal gammopathy of unknown significance with autoimmune diseases
(
- Contribution to journal › Letter
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
White matter lesions highly influence group comparison of diffusion tensor imaging metrics
2016) ISMRM, 2016(
- Contribution to conference › Poster